Raymond Dwek
Director/Board Member bij UNITED THERAPEUTICS CORPORATION
Vermogen: 402 010 $ op 31-03-2024
Actieve functies van Raymond Dwek
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
UNITED THERAPEUTICS CORPORATION | Director/Board Member | 01-01-2002 | - |
Independent Dir/Board Member | 01-01-2002 | - |
Loopbaan van Raymond Dwek
Eerdere bekende functies van Raymond Dwek
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Oxford Glycobiology Institute | Director/Board Member | 01-01-1988 | 01-01-2021 |
Institute of Biology | President | 01-01-2008 | 01-01-2010 |
University of Oxford | Corporate Officer/Principal | 01-01-1988 | 01-01-2009 |
Oxford GlycoSciences Plc
Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Director/Board Member | 01-01-1988 | 01-01-2003 |
Corporate Officer/Principal | 01-01-1988 | 01-01-2003 | |
The Library of Congress (District of Columbia) | Corporate Officer/Principal | 01-01-2007 | - |
Opleiding van Raymond Dwek
University of Oxford | Graduate Degree |
Statistieken
Internationaal
Verenigd Koninkrijk | 5 |
Verenigde Staten | 3 |
Operationeel
Director/Board Member | 3 |
Corporate Officer/Principal | 3 |
Independent Dir/Board Member | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 3 |
Government | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
UNITED THERAPEUTICS CORPORATION | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Oxford GlycoSciences Plc
Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Health Technology |
The Library of Congress (District of Columbia) | Government |
Institute of Biology |
- Beurs
- Insiders
- Raymond Dwek
- Ervaring